Dr Farquharson is the Senior Director of Global Medical Affairs for Preclinical Alzheimer’s Disease (AD) at Eli Lilly and Company. She leverages her clinical and scientific expertise to shape global medical strategy in preclinical AD, specifically focusing on the European and Middle Eastern (EMEA) regions. Prior to joining Lilly, she was the EMEA Regional Medical Advisor for Alzheimer’s Disease at Eisai. Dr Farquharson is a GMC-qualified physician with a clinical background in the NHS and has a Masters in Experimental Neuroscience from Imperial College, London.
